Targeting Rare Biomarkers: A New Frontier in Non-Small Cell Lung...

agregó una foto Health

2025-04-10 11:11:57

Targeting Rare Biomarkers: A New Frontier in Non-Small Cell Lung Cancer Treatment

Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related deaths worldwide. Recent breakthroughs in understanding the molecular underpinnings of NSCLC have highlighted the importance of rare biomarkers in optimizing treatment options. The discovery of these biomarkers has paved the way for targeted therapies that have drastically altered the treatment landscape. As we...

0 Commentarios 0 Acciones 166 Views 0 Vista previa